Article Data

  • Views 730
  • Dowloads 177

Systematic review

Open Access

The efficacy and safety of thulium laser resection of bladder tumor versus standard transurethral resection in patients with non-muscle-invasive bladder cancer: a systematic review and meta-analysis

  • Yu-Meng Chai1,†
  • Yuan-Shan Cui1,2,†
  • Xiao-Yi Zhang3
  • Huan-Tao Zong1
  • Zhong-Bao Zhou1
  • Yong Zhang1

1Department of Urology, Beijing Tiantan Hospital, Capital Medical University, 100070 Beijing, P. R. China

2Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, 266101 Shandong, P. R. China

3Department of Urology, PLA Rocket Force Characteristic Medical Center, 100088 Beijing, P. R. China

DOI: 10.31083/jomh.2021.023 Vol.17,Issue 2,April 2021 pp.32-42

Published: 08 April 2021

*Corresponding Author(s): Yong Zhang E-mail: doctorzhy@126.com

† These authors contributed equally.

PDF (4.42 MB)

Abstract

Purpose: This study was to analyze the efficacy and safety of thulium laser resection of bladder tumor (Tm-TURBT) versus TURBT for patients with non-muscle-invasive bladder cancer (NMIBC).

Materials and Methods: Randomized controlled trial data were retrieved using the MEDLINE, Embase, Web of Science, and the Cochrane Library. We also searched Chinese databases including Chinese National Knowledge Infrastructure (CNKI), Wanfang data and VIP data.

Results: A total of sixteen articles including 1662 participants were enrolled into our meta-analysis. We found no significant difference in terms of operation time, urethral stricture, 1-year recurrence rate, overall 1-year recurrence rate and overall 3-year recurrence rate between the two groups. Less intraoperative blood loss and a lower incidence of obturator nerve reflex (ONR), bladder perforation and bladder irritation were identified in Tm-TURBT group than in TURBT group in our analysis. The analysis also demonstrated faster postoperative recovery in terms of the catheterization, bladder irrigation and hospitalization time in Tm-TURBT group. The subgroup analysis was conducted based on different postoperative chemotherapy (epirubicin and non-epirubicin) concerning recurrence rate whereas no significant difference was noted.

Conclusion: Tm-TURBT is an efficient and safe treatment for NMIBC and it could be an alternative choice for TURBT. Given that some limitations are clearly identified, more large-scale and well-designed RCTs are needed to confirm our findings.

Keywords

Transurethral resection of bladder tumor; Bladder tumor; Thulium laser; Meta-analysis; Randomized controlled trials

Cite and Share

Yu-Meng Chai,Yuan-Shan Cui,Xiao-Yi Zhang,Huan-Tao Zong,Zhong-Bao Zhou,Yong Zhang. The efficacy and safety of thulium laser resection of bladder tumor versus standard transurethral resection in patients with non-muscle-invasive bladder cancer: a systematic review and meta-analysis. Journal of Men's Health. 2021. 17(2);32-42.

References

[1] Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2018; 68: 394-424.

[2] Burger M, Catto JWF, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, et al. Epidemiology and risk factors of urothelial bladder cancer. European Urology. 2013; 63: 234-241.

[3] Ploeg M, Aben KKH, Kiemeney LA. The present and future burden of urinary bladder cancer in the world. World Journal of Urology. 2009; 27: 289-293.

[4] Babjuk M, Böhle A, Burger M, Capoun O, Cohen D, Compérat EM, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. European Urology. 2017; 71: 447-461.

[5] Nishiyama H. Asia consensus statement on NCCN clinical practice guideline for bladder cancer. Japanese Journal of Clinical Oncology. 2018; 48: 3-6.

[6] Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Journal of Clinical Epidemiology. 2009; 62: 1006-1012.

[7] Higgins JPT TJ, Chandler J, Cumpston M, Li T, Page MJ, Welch VA. Cochrane handbook for systematic reviews of interventions version 6.0. 2019. Available at: www.training.cochrane.org/handbook

[8] DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials. 1986; 7: 177-188.

[9] Cao KW, Ji HX, Pan JH, Chen ZW, Dai Q. Comparison of transurethral 2-micron laser resection and electrocision for superficial bladder cancer. Progress in Modern Biomedicine. 2015; 15. (In Chinese)

[10] Chen X, Liao J, Chen L, Qiu S, Mo C, Mao X, et al. En bloc transurethral resection with 2-micron continuous-wave laser for primary non-muscle-invasive bladder cancer: a randomized controlled trial. World Journal of Urology. 2015; 33: 989-995.

[11] Chen K, Zhang N, Ge L. Efficacy analysis of thulium laser transurethral resection for superficial bladder tumor. The Journal of Medical Theory and Practice. 2019; 32: 1180-1181. (In Chinese)

[12] Guan QJ, Shan ZJ, Han QH, Ma JF. Efficacy analysis of en bloc transurethral resection with thulium laser for non-muscle invasive bladder cancer. Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine. 2017; 17. (In Chinese)

[13] Hu YY, Niu XZ, Wang GC, Huang JH, Liu M, Peng B. Comparative study of 2 µm laser, holmium laser and transurethral resection for non-muscle invasive bladder cancer. Journal of Clinical and Pathological Research. 2016; 9: 23618-23623.

[14] Li J, Fan LH, Liu L, Bi XJ. The efficacy comparison of transurethral 2- micron laser ablation and annular electrode in the treatment of superficial bladder tumor. Chinese Medical Journal of Metallurgical Industry. 2017; 34: 130-132. (In Chinese)

[15] Liu H, Wu J, Xue S, Zhang Q, Ruan Y, Sun X, et al. Comparison of the safety and efficacy of conventional monopolar and 2-micron laser transurethral resection in the management of multiple nonmuscle-invasive bladder cancer. The Journal of International Medical Re-search. 2013; 41: 984-992.

[16] Liu B. Efficacy analysis of thulium laser transurethral resection of bladder tumor. Medical Journal of Chinese People’s Health. 2017; 29.(In Chinese)

[17] Luo GH, Liu J, Wang YL, He J, Yang XS, Chen WH, et al. Efficacy analysis of 2-micron Iaser treatment in non muscle-invasive bladder cancer. Journal of Contemporary Urologic and Reproductive Oncology. 2010; 2. (In Chinese)

[18] Shen P, Ou TW, Xu JJ, Wang SH, Gao W, Chen XS. Clinical comparative study of 2 µm continuous wave laser resection and transurethral resection for superficial bladder tumor. Journal of Modern Urology. 2011; 16. (In Chinese)

[19] Wang YB, Lu YA, Shao JK, Li XD. Comparison of 2 µm contlnuous-wave laser resection and transurethral resection of bladder tumor for nonmusde-invasive bladder tumor. Cancer Research and Clinic. 2012; 24: 321-323.

[20] Wang TM, Song YS, Yang L. Clinical study of 2-micron laser resection in Ta, T1 and Tis bladder cancer. Hebei Medical Journal. 2017; 39. (In Chinese)

[21] Wu XM, He Y, Chen H. Comparison of the efficacy of thulium laser transurethral resection and electrosurgical resection in the treatment of bladder tumor. Zhejiang Clinical Medical Journal. 2016; 18. (In Chinese)

[22] Wu HB, He F, Zhao ZX, Liu ZH, Zhong LT, Zhu JY. Efficacy analysis of superficial bladder tumor treated by transurethral thulium laser resection. Acta Medicinae Sinica. 2017; 30. (In Chinese)

[23] Zhang X, Feng C, Zhu W, Si J, Gu B, Guo H, et al. Two micrometer continuous-wave thulium laser treating primary non-muscle-invasive bladder cancer: is it feasible? A randomized prospective study. Photomedicine and Laser Surgery. 2015; 33: 517-523.

[24] Zhang B, Zhu YH. Efficacy analysis of 2-micron laser resection for non-muscle invasive bladder tumor. China Health Care & Nutrition. 2017; 27: 307-308. (In Chinese)

[25] Sievert KD, Amend B, Nagele U, Schilling D, Bedke J, Horstmann M, et al. Economic aspects of bladder cancer: what are the benefits and costs? World Journal of Urology. 2009; 27: 295-300.

[26] Gregg JR, McCormick B, Wang L, Cohen P, Sun D, Penson DF, et al. Short term complications from transurethral resection of bladder tumor. The Canadian Journal of Urology. 2016; 23: 8198-8203.

[27] Shah NF, Sofi KP, Nengroo SH. Obturator nerve block in transurethral resection of bladder tumor: a comparison of ultrasound-guided tech-nique versus ultrasound with nerve stimulation technique. Anesthesia, Essays and Researches. 2017; 11: 411-415.

[28] Mariappan P, Zachou A, Grigor KM. Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. European Urology. 2010; 57: 843-849.

[29] Xu J, Wang C, Ouyang J, Sun J, Hu C. Efficacy and safety of transurethral laser surgery versus transurethral resection for non-muscle-invasive bladder cancer: a meta-analysis and systematic review. Urologia Internationalis. 2020; 104: 810-823.

[30] Huang SW, Tsai CY, Tseng CS, Shih MC, Yeh YC, Chien KL, et al. Comparative efficacy and safety of new surgical treatments for benign prostatic hyperplasia: systematic review and network meta-analysis. BMJ. 2019; 367: l5919.

[31] Enikeev D, Shariat SF, Taratkin M, Glybochko P. The changing role of lasers in urologic surgery. Current Opinion in Urology. 2020; 30: 24-29.

[32] Rapoport L, Vinarov A, Enikeev D, Sorokin N, Dymov A, Sukhanov R, et al. Technical aspects of transurethral thulium laser en bloc resection of bladder tumors. Journal of Endourology. 2018; 32: A511.

[33] Kramer MW, Rassweiler JJ, Klein J, Martov A, Baykov N, Lusuardi L, et al. En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor. World Journal of Urology. 2015; 33: 1937-1943.

[34] Wolters M, Kramer MW, Becker JU, Christgen M, Nagele U, Imkamp F, et al. Tm: YAG laser en bloc mucosectomy for accurate staging of primary bladder cancer: early experience. World Journal of Urology. 2011; 29: 429-432.

[35] Kramer MW, Wolters M, Cash H, Jutzi S, Imkamp F, Kuczyk MA, et al. Current evidence of transurethral Ho:YAG and Tm:YAG treatment of bladder cancer: update 2014. World Journal of Urology. 2015; 33: 571- 579.

[36] Migliari R, Buffardi A, Ghabin H. Thulium laser endoscopic en bloc enucleation of nonmuscle-invasive bladder cancer. Journal of Endourology. 2015; 29: 1258-1262.

[37] Collado A, Chéchile GE, Salvador J, Vicente J. Early complications of endoscopic treatment for superficial bladder tumors. The Journal of Urology. 2000; 164: 1529-1532.

[38] Wendt-Nordahl G, Huckele S, Honeck P, Alken P, Knoll T, Michel MS, et al. Systematic evaluation of a recently introduced 2-microm continuous-wave thulium laser for vaporesection of the prostate. Journal of Endourology. 2008; 22: 1041-1045.

[39] Mydlo JH, Weinstein R, Shah S, Solliday M, Macchia RJ. Long-term consequences from bladder perforation and/or violation in the presence of transitional cell carcinoma: results of a small series and a review of the literature. The Journal of Urology. 1999; 161: 1128-1132.

[40] Clavien PA, Sanabria JR, Strasberg SM. Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery. 1992; 111: 518-526.

[41] Dindo D, Demartines N, Clavien P. Classification of surgical compli-cations: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Annals of Surgery. 2004; 240: 205-213.

[42] Sedaghat S, Gheytanchi E, Asgari M, Roudi R, Keymoosi H, Madjd Z. Expression of cancer stem cell markers OCT4 and CD133 in transitional cell carcinomas. Applied Immunohistochemistry & Molecular Morphology. 2017; 25: 196-202.

[43] Kamat AM, Briggman J, Urbauer DL, Svatek R, Nogueras González GM, Anderson R, et al. Cytokine panel for response to intravesical therapy (CyPRIT): nomogram of changes in urinary cytokine levels predicts patient response to Bacillus Calmette-Guérin. European Urology. 2016; 69: 197-200.

[44] Teoh JY, MacLennan S, Chan VW, Miki J, Lee H, Chiong E, et al. An international collaborative consensus statement on en bloc resection of bladder tumour incorporating two systematic reviews, a two-round delphi survey, and a consensus meeting. European Urology. 2020; 78: 546- =569.

[45] Xie K, Cao D, Wei Q, Ren Z, Li J, Li Y, et al. Bipolar versus monopolar transurethral resection of non-muscle-invasive bladder cancer: a systematic review and meta-analysis of randomized controlled trials. World Journal of Urology. 2020. (in press)

[46] Sharma G, Tyagi S. Comment on “Bipolar versus monopolar transurethral resection of non-muscle-invasive bladder cancer: a systematic review and meta-analysis of randomized controlled trials”. World Journal of Urology. 2020. (in press)

[47] Tao W, Yang D, Shan Y, Xue B, Sun C, Zang Y, et al. Safety and efficacy of 120W high performance system greenlight laser vaporization for non-muscle-invasive bladder cancer. Journal of X-Ray Science and Technology. 2013; 21: 309-316.

[48] Poletajew S, Krajewski W, Gajewska D, Sondka-Migdalska J, Borowik M, Buraczyński P, et al. Prediction of the risk of surgical complications in patients undergoing monopolar transurethral resection of bladder tumour-a prospective multicentre observational study. Archives of Medical Science. 2020; 16: 863-870.

Abstracted / indexed in

Science Citation Index Expanded Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Social Sciences Citation Index Social Sciences Citation Index contains over 3,400 journals across 58 social sciences disciplines, as well as selected items from 3,500 of the world’s leading scientific and technical journals. More than 9.37 million records and 122 million cited references date back from 1900 to present.

Current Contents - Social & Behavioral Sciences Current Contents - Social & Behavioral Sciences provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in the social and behavioral sciences.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

SCOPUS Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

DOAJ DOAJ is a community-curated online directory that indexes and provides access to high quality, open access, peer-reviewed journals.

CrossRef Crossref makes research outputs easy to find, cite, link, assess, and reuse. Crossref committed to open scholarly infrastructure and collaboration, this is now announcing a very deliberate path.

Portico Portico is a community-supported preservation archive that safeguards access to e-journals, e-books, and digital collections. Our unique, trusted process ensures that the content we preserve will remain accessible and usable for researchers, scholars, and students in the future.

Submission Turnaround Time

Conferences

    Top